This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2023 Remove Computer and Electronics Remove Healthcare Remove Risk
article thumbnail

Redefining clinical trials: Adopting AI for speed, volume and diversity

IBM Big Data Hub

MAY 6, 2024

The FDA, in its May 2023 draft guidance, backed the adoption of DCTs across drugs, biologics and medical devices , highlighting their merits such as enhanced patient convenience, diminished caregiver burden, broader access to varied demographics, amplified trial productivity, and support for research on rare or mobility-restricted patient groups.

Computer and Electronics 80
Computer and Electronics Healthcare Artificial Intelligence Marketing 80
article thumbnail

EU: NIS2 enters into force

DLA Piper Privacy Matters

JANUARY 26, 2023

On 16 January 2023, the Directive on measures for a high common level of cybersecurity across the Union (“ NIS2 ”) entered into force. Management bodies of essential and important entities will have to approve these cybersecurity risk management measures, supervise their implementation and be liable for non-compliance by the entity.

Computer and Electronics 52
Computer and Electronics Cybersecurity Risk Manufacturing 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 55,000+ Insiders by signing up for our newsletter

About
Awards
About
Editions
Awards
Editions
Topics
Twitter
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024